HLS Therapeutics Inc. (FRA:74D)

HLS Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	94	84	87	220	338	367
Market Cap Growth	35.56%	-3.35%	-60.57%	-34.93%	-7.74%	-32.63%
Enterprise Value	132	130	151	295	407	444
Last Close Price	2.86	2.56	2.50	6.41	9.55	10.24
PS Ratio	1.98	1.53	1.52	3.83	6.41	7.99
PB Ratio	1.80	1.22	0.98	1.88	2.39	2.65
P/FCF Ratio	8.12	10.87	6.09	13.92	23.48	48.18
P/OCF Ratio	8.02	10.85	6.08	13.88	23.41	47.99
EV/Sales Ratio	2.75	2.38	2.64	5.12	7.71	9.67
EV/EBITDA Ratio	8.96	8.99	7.74	15.14	19.78	26.32
EV/FCF Ratio	11.32	16.88	10.57	18.63	28.26	58.31
Debt / Equity Ratio	0.88	0.93	0.90	0.78	0.61	0.65
Debt / EBITDA Ratio	3.15	4.42	4.06	4.66	4.07	5.17
Debt / FCF Ratio	3.97	8.32	5.56	5.76	5.96	11.73
Asset Turnover	0.36	0.31	0.28	0.24	0.21	0.18
Inventory Turnover	2.13	1.58	1.43	1.20	0.99	1.43
Quick Ratio	0.81	1.11	1.22	1.02	1.18	0.93
Current Ratio	1.17	1.57	1.65	1.42	1.58	1.29
Return on Equity (ROE)	-20.02%	-23.25%	-24.69%	-16.50%	-7.95%	-8.82%
Return on Assets (ROA)	-1.86%	-2.60%	-2.87%	-3.26%	-1.35%	-2.42%
Return on Capital (ROIC)	-2.20%	-2.97%	-3.17%	-3.51%	-1.46%	-2.74%
Return on Capital Employed (ROCE)	-4.00%	-5.60%	-5.70%	-6.40%	-2.50%	-4.50%
Earnings Yield	-12.74%	-22.63%	-28.70%	-10.03%	-3.41%	-3.42%
FCF Yield	12.31%	9.20%	16.42%	7.18%	4.26%	2.08%
Dividend Yield	-	-	2.74%	2.16%	1.46%	1.25%
Buyback Yield / Dilution	0.81%	1.31%	0.52%	-0.77%	-1.48%	-8.01%
Total Shareholder Return	0.81%	1.31%	3.26%	1.38%	-0.03%	-6.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.